Cellectis SA
PAR:ALCLS

Watchlist Manager
Cellectis SA Logo
Cellectis SA
PAR:ALCLS
Watchlist
Price: 1.336 EUR -0.45% Market Closed
Market Cap: 96.3m EUR

Wall Street
Price Targets

ALCLS Price Targets Summary
Cellectis SA

Wall Street analysts forecast ALCLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.

Lowest
Price Target
6.565 EUR
391% Upside
Average
Price Target
6.63 EUR
396% Upside
Highest
Price Target
6.825 EUR
411% Upside
Cellectis SA Competitors:
Price Targets
688235
Beigene Ltd
14% Upside
REGN
Regeneron Pharmaceuticals Inc
40% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
27% Upside
KALV
Kalvista Pharmaceuticals Inc
142% Upside
SVE
Synthaverse SA
21% Upside
6855
Ascentage Pharma Group International
8% Upside
NYKD
Nykode Therapeutics ASA
107% Upside
BCYC
Bicycle Therapeutics PLC
235% Upside

Revenue
Forecast

Revenue Estimate
Cellectis SA

For the last 8 years the compound annual growth rate for Cellectis SA's revenue is -2%. The projected CAGR for the next 3 years is 9%.

-2%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALCLS's stock price target?
Price Target
6.63 EUR

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.

What is Cellectis SA's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Cellectis SA's revenue is -2%. The projected CAGR for the next 3 years is 9%.

Back to Top